我国分省心血管病救治的现况评价—中国心血管健康指数解析

目的评价我国整体及分省心血管疾病的救治情况现状。方法本研究涉及的资料与数据来源于中国心血管健康指数（CHI）（2017）研究结果。 选取CHI“疾病救治情况”维度的15个指标测算和分析全国31个省、自治区、直辖市（不含港澳台地区）的具体情况，并对全国和分省心血管疾病的救治情况CHI得分进行排名比较。 CHI（2017）“疾病救治情况”维度各指标满分为100分，得分越高提示心血管疾病的救治情况越好。结果2017年我国心血管疾病救治情况得分平均分为44.04分。 区域分析结果显示，我国南方地区心血管疾病的救治情况得分为47.29分，高于北方地区（39.51分）；东部地区得分为46.93分，高于中部地区（41.08分）和西部地区（42.48分）。 分省数据显示，北京市得分最高（62.01分），其次是浙江省（61.73分）、上海市（61.72分）、湖南省（60.96分）和海南省（60.39分）。 宁夏回族自治区得分最低（27.11分），其他得分较低的省份有辽宁省（28.16分）、安徽省（34.56分）、云南省（35.09分）、内蒙古自治区（35.23分）。结论我国区域间心血管疾病救治情况存在差异，体现出南方优于北方，东部、南部沿海地区心血管疾病救治情况优于其他地区的特点。

Evaluation of current status of cardiovascular disease treatment by province in China-data from China Cardiovascular Health Index

ObjectiveTo evaluate the current status of cardiovascular disease treatment in China.MethodsThe materials and data used in this study were from the research results of Cardiovascular Health Index (CHI) (2017) in China. Fifteen indicators from the dimension of "disease treatment" of CHI (2017) were selected to measure and analyze the conditions of 31 provinces, autonomous regions and municipalities in China, excluding Hong Kong, Macao and Taiwan. The scores of CHI in the treatment of cardiovascular diseases in China were ranked and compared by province. The full score of each index in CHI "disease treatment" dimension was 100, and higher score indicated better treatment of cardiovascular diseases.ResultsIn 2017, the average score of cardiovascular disease treatment was 44.04 in China. Area specific analysis results showed that the score of cardiovascular disease treatment in southern China was 47.29, which was higher than that in northern China (39.51). The score in eastern China was 46.93, higher than that in central China (41.08) and in western China (42.48). The highest score was in Beijing (62.01), followed by Zhejiang (61.73), Shanghai (61.72), Hunan (60.96) and Hainan (60.39). The lowest score was in Ningxia (27.11), while other provinces with lower scores were Liaoning (28.16), Anhui (34.56), Yunnan (35.09) and Inner Mongolia (35.23).ConclusionThe performance of cardiovascular disease treatment varied with area in China, characterized by the better treatment in southern China than in the northern China, and the better treatment in eastern China and southern coastal area than in other areas.